Fortrea is a company operating within the Business Services sector, with a focus on research and development in the biotechnology and pharmaceutical industries. Established in 2006 and based in the United States, Fortrea specializes in clinical laboratory services and patient safety solutions. The company's document corpus highlights its involvement in early-phase oncology clinical trials, addressing challenges such as patient recruitment, regulatory complexity, and operational sustainability. Fortrea emphasizes the need for collaboration among stakeholders in clinical research to enhance the viability of oncology trials. Additionally, the company provides comprehensive strategies for assessing the abuse liability of new drug compounds, particularly those targeting the central nervous system. Its patient safety services span the entire product lifecycle, incorporating advanced automation technologies to improve operational efficiencies and compliance with regulatory requirements. Fortrea's publications reflect its commitment to addressing critical issues in drug development and patient safety, positioning itself as a knowledgeable entity in the biotech and pharmaceutical landscape.